Renal sympathetic nerve activity is increased in monosodium glutamate induced hyperadipose rats

Neuroscience Letters

Volumn 522, Issue 2, 2012, Pages 118-122

  da Silva Mattos, Alexandro Márcio ^a   Xavier, Carlos Henrique ^c   Karlen Amarante, Marlusa ^a   da Cunha, Natália Veronez ^a   Fontes, Marco Antonio Peliky ^b   Martins Pinge, Marli Cardoso ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Autonomic; Hypertension; Obesity; Renal; Sympathetic

Indexed keywords

GLUTAMATE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RENAL SYMPATHETIC NERVE ACTIVITY; SYMPATHETIC NERVE;

ADIPOSITY; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; HEART RATE; HYPERTENSION; KIDNEY; MALE; OBESITY; RATS; RATS, WISTAR; SODIUM GLUTAMATE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84863875582     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.021     Document Type: Article

References (47)

1. Alvarez G.E., Beske S.D., Ballard T.P., Davy K.P. Sympathetic neural activation in visceral obesity. Circulation 2002, 106:2533-2536.
2. Barnes M.J., Lapanowski K., Conley A., Rafols J.A., Jen K.L., Dumbar J.C. Hight fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic μ-opioid receptors. Brain Research Bulletin 2003, 61:511-519.
3. Chen F., Cham J.L., Badoer E. High-fat feeding alters the cardiovascular role of the hypothalamic paraventricular nucleus. American Journal of Physiology: Regulatory, Integrative, and Comparative Physiology 2010, 298:R799-R807.
4. Collins S., Kuhn C.M., Petro A.E., Swick A.G., Chrunyk B.A., Surwit R.S. Role of leptin in fat regulation. Nature 1996, 380:677.
5. Correia M.L., Morgan D.A., Sivitz W.I., Mark A.L., Haynes W.G. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001, 37:936-942.
6. Cunha N.V., de Abreu S.B., Panis C., Grassiolli S., Guarnier F.A., Cecchini R., Mazzuco T.L., Pinge-Filho P., Martins-Pinge M.C. Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. Life Sciences 2010, 87:375-381.
7. Da Cunha N.V., Pinge-Filho P., Neto O.B., Grassiolli S., Martins-Pinge M.C. Cox-2 inhibition does not reverse the increased sympathetic modulation in msg obese rats. Autonomic Neuroscience 2011, 165:201-204.
8. Dawson R., Pelleymounter M.A., Millard W.J., Liu S., Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. American Journal of Physiology 1997, 273:E202-E206.
9. DiBona G.F. Neural control of the kidney: functionally specific renal sympathetic nerve fibers. American Journal of Physiology: Regulatory, Integrative, and Comparative Physiology 2000, 279:R1517-R1524.
10. Esler M., Straznicky N., Eikelis N., Masuo K., Lambert G., Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006, 48:787-796.
11. Gomes da Silva A.Q., Xavier C.H., Campagnole-Santos M.J., Caligiorne S.M., Baltatu O., Bader M., Santos R.A.S., Fontes M.A.P. Cardiovascular responses evoked by activation or blockade OF GABAA receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen. Brain Research 2012, 1448:101-110.
12. Grassi G., Dell'Oro R., Quarti-Trevano F., Scopelliti F., Seravalle G., Paleari F. Neuroadrenergic and reflex abnormalities in patients with the metabolic syndrome. Diabetologia 2005, 48:1359-1365.
13. Grassi G., Servalle G., Cattaneo B.M., Bolla G.B., Lanfranchi A., Colombo M., Gianattasio C., Brunani A., Cavagnini F., Mancia G. Sympathetic activity in obese normotensive subjects. Hypertension 1995, 25:560-563.
14. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertension Research 2006, 29:839-847.
15. Grassi G. Sympathetic neural activity in hypertension and related diseases. American Journal of Hypertension 2010, 23:1052-1060.
16. Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., Sivitz W.I. Receptor-mediated regional sympathetic nerve activation by leptin. Journal of Clinical Investigation 1997, 100:270-278.
17. Hamza S.M., Kaufman S. Effect of mesenteric vascular congestion on reflex control of renal blood flow. American Journal of Physiology: Integrative and Comparative Physiology 2007, 293:R1917-R1922.
18. Hirata A.E., Andrade I.S., Vaskevicius P., Dolnikoff M.S. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Brazilian Journal of Medical and Biological Research 1997, 30:671-674.
19. Huggett R.J., Burns J., Mackintosh A.F., Mary D.A. Sympathetic neural activation in nondiabetic metabolic syndrome its further augmentation by hypertension. Hypertension 2004, 44:1-6.
20. Iwashita S., Tanida M., Terui N., Ootsuka Y., Shu M., Kang D., Suzuki M. Direct measurement of renal sympathetic nervous activity in high-fat diet-related hypertensive rats. Life Sciences 2002, 71:537-546.
21. M. Karlen-Amarante, N.V. da Cunha, O. de Andrade, H.C. de Souza, M.C. Martins-Pinge. Altered baroreflex and autonomic modulation in monosodium glutamate-induced hyperadipose rats. Metabolism, doi:10.1016/j.metabol.2012.03.005.
22. Kizer J.S., Nemeroff C.B., Youngblood W.W. Neurotoxic amino acids and structurally related analogs. Pharmacological Reviews 1978, 29:301-318.
23. Macho L., Fickova M., Jezova R., Zorad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiological Research 2000, 49:S79-S85.
24. Maletínská L., Toma R.S., Pirnik Z., Diss A., Slaninová J., Haluzik M., ŽeleznáF B. Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice. Regulatory Peptides 2006, 136:58-63.
25. Mark A.L., Agassandian K., Morgan D.A., Liu X., Cassell M.D., Rahmouni K. Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension 2009, 53:375-380.
26. Marsh A.J., Fontes M.A., Killinger S., Pawlak D.B., Polson J.W., Dampney R.A. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 2003, 42:488-493.
27. Mathias P.C., Grassiolli S., Rocha D.N., Scomparin D.X., Gravena C. Transplantation of pancreatic islets from hypothalamic obese rats corrects hyperglycemia of diabetic rats. Transplantation Proceedings 2007, 39:193-195.
28. Moreno G., Perelló M., Camihort G., Luna G., Console G., Gaillard R.C., Spinedi E. Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rats. International Journal of Obesity (London) 2006, 30:73-82.
29. Morgan D.A., Anderson E.A., Mark A.L. Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 1995, 25:834-838.
30. Morgan D.A., Thedens D.R., Weiss R., Rahmouni K. Mechanisms mediating renal sympathetic activation to leptin in obesity. American Journal of Physiology: Regulatory, Integrative, and Comparative Physiology 2008, 295:R1730-R1736.
31. Perelló M., Moreno G., Camihort G., Luna G., Cónsole G., Gaillard R.C., Spinedi E. Nature of changes in adrenocortical function in chronic hyperleptinemic female rats. Endocrinology 2004, 24:167-175.
32. Perello M., Castrogiovanni D., Giovambattista A., Gaillard R.C., Spinedi E. Prolonged but not short negative energy condition restored corticoadrenal leptin sensitivity in the hypothalamic obese rat. Neuroendocrinology 2009, 89:276-287.
33. Pintérová L., Zelezná B., Ficková M., Macho L., Krizanová O., Jezová D., Zórad S. Elevated AT1 receptor protein but lower angiotensin II-binding in adipose tissue of rats with monosodium glutamate-induced obesity. Hormone and Metabolic Research 2001, 33:708-712.
34. Prior L.J., Eikelis N., Armitage J.A., Davern P.J., Burke S.L., Montani J.P., Barzel B., Head G.A. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010, 55:862-868.
35. Rahmouni K., Correia M.L., Haynes W.G., Mark A.L. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005, 45:9-14.
36. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Current Hypertension Reviews 2010, 6:104-209.
37. Rana J.S., Nieuwdorp M., Jukema J.W., Kastelein J.J. Cardiovascular metabolic syndrome - an interplay of obesity inflammation, diabetes and coronary heart disease. Diabetes, Obesity and Metabolism 2007, 9:218-232.
38. Romagnano M.A., Pilcher W.H., Bennett-Clarke C., Chafel T.L., Joseph S.A. Distribution of somatostatin in the mouse brain: effects of neonatal MSG treatment. Brain Research 1982, 234:387-398.
39. Sarafidis P.A. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Current Opinion in Nephrology and Hypertension 2008, 17:450-456.
40. Scheuer D.A., Mifflin S.W. Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity. American Journal of Physiology: Regulatory, Integrative, and Comparative Physiology 2001, 280:R1440-R1449.
41. Shek E.W., Brands M.W., Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409-414.
42. Souza H.C., Martins-Pinge M.C., Dias da Silva V.J., Borghi-Silva A., Gastaldi A.C., Blanco J.H., Tezini G.C. Heart rate and arterial pressure variability in the experimental renovascular hypertension model in rats. Autonomic Neuroscience 2008, 139:38-45.
43. Stocker S.D., Meador R., Adams J.M. Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension 2007, 49:640-646.
44. Straznicky N., Eikelis N., Lambert E., Esler M. Mediators of sympathetic activation in metabolic syndrome obesity. Current Hypertension Reports 2008, 10:440-447.
45. Vaz M., Jennings G., Turner A., Cox H., Lambert G., Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 96:3423-3429.
46. Zelezná B., Maixnerová J., Matyšková R., Haugvicová R., Blokešová D., Maletínská L. Anorexigenic effect of cholecystokinin is lost but that of CART (cocaine and amphetamine regulated transcript) peptide is preserved in monosodium glutamate obese mice. Physiological Research 2008, 58:717-723.
47. Zorad S., Jezova D., Szabova L., Macho L., Tybitanclova K. Low number of insulin receptors but high receptor protein content in adipose tissue of rats with monosodium glutamate-induced obesity. General Physiology and Biophysics 2003, 22:557-560.